DHG Pharmaceutical JSC (STC:DHG) Moat Score: 0/10 (As of Jul. 02, 2026)


STC:DHG DHG Pharmaceutical JSC STC:DHG
80 GF Score
Price ₫93,200.00
GF Value ₫113,527.85
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DHG Pharmaceutical JSC Moat Score?

DHG Pharmaceutical JSC has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

DHG Pharmaceutical JSC has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes DHG Pharmaceutical JSC might have No Moat - No discernible moat.

DHG Pharmaceutical JSC  (STC:DHG) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

DHG Pharmaceutical JSC Moat Score Related Terms

STC:DHG
80GF Score
DHG Pharmaceutical JSC STC:DHG
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?

Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued. The current stock price of ₫93,200.00 is trading 17.9% below its estimated GF Value™ of ₫113,527.85. GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.

Key valuation signals for STC:DHG:

  • Moat Score: 0
  • GF Value™: ₫113,527.85 vs. price of ₫93,200.00 (17.9% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DHG Pharmaceutical JSC Business Description

Address 288 Bis Nguyen Van Cu, An Hoa Ward, Ninh Kieu District, Can Tho, VNM
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
80GF Score

Get the complete analysis for STC:DHG

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫93,200.00
Price
₫113,527.85
GF Value